Meprobamate
Meprobamate (marketed as Mogadon) was withdrawn from markets in the EU on recommendation from the EMA in 2012. Yet, the drug remains available in the UK, albeit with the comment that it is not recommended.
Subscribe to:
Posts (Atom)